PKM2 Expression as Biomarker for Resistance to Oxaliplatin-Based Chemotherapy in Colorectal Cancer.
BRAF
MSI
PKM2
colon cancer
prediction
ΚRAS
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
25 Jul 2020
25 Jul 2020
Historique:
received:
17
06
2020
revised:
21
07
2020
accepted:
22
07
2020
entrez:
30
7
2020
pubmed:
30
7
2020
medline:
30
7
2020
Statut:
epublish
Résumé
The purpose of the current study is to investigate the prognostic significance of M2 isoform of pyruvate kinase (PKM2)
Identifiants
pubmed: 32722474
pii: cancers12082058
doi: 10.3390/cancers12082058
pmc: PMC7465271
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Nature. 2011 Dec 1;480(7375):118-22
pubmed: 22056988
Int J Clin Exp Pathol. 2015 Sep 01;8(9):11393-9
pubmed: 26617865
Arch Biochem Biophys. 2016 May 15;598:50-6
pubmed: 27040384
Nat Commun. 2014 Nov 21;5:5566
pubmed: 25412762
Colorectal Dis. 2008 Mar;10(3):244-8
pubmed: 17784868
Mol Cancer Ther. 2009 Apr;8(4):771-8
pubmed: 19372549
Br J Cancer. 2009 Aug 4;101(3):465-72
pubmed: 19603024
Clin Colorectal Cancer. 2013 Sep;12(3):168-78
pubmed: 23773459
IUBMB Life. 2012 Sep;64(9):775-82
pubmed: 22807066
Oncotarget. 2017 Nov 20;8(66):110656-110670
pubmed: 29299177
Nature. 2008 Mar 13;452(7184):230-3
pubmed: 18337823
J Cell Biochem. 2010 Mar 1;109(4):625-33
pubmed: 20082317
Int J Cancer. 2004 Feb 10;108(4):532-9
pubmed: 14696117
Trends Biochem Sci. 2016 Mar;41(3):211-218
pubmed: 26778478
JAMA Oncol. 2018 Nov 1;4(11):1553-1568
pubmed: 29860482
Nat Med. 2004 Aug;10(8):789-99
pubmed: 15286780
Cancer Res Treat. 2019 Oct;51(4):1518-1526
pubmed: 30913862
Pathol Res Pract. 2013 Aug;209(8):510-5
pubmed: 23880164
Mol Cancer Ther. 2009 Jan;8(1):194-202
pubmed: 19139129
Br J Cancer. 2014 Oct 28;111(9):1757-64
pubmed: 25233397
Trends Biochem Sci. 2019 Jun;44(6):490-501
pubmed: 30655165
N Engl J Med. 2018 Mar 29;378(13):1177-1188
pubmed: 29590544
Ann Oncol. 2013 Oct;24 Suppl 6:vi64-72
pubmed: 24078664
Sci Rep. 2016 Aug 05;6:30788
pubmed: 27492148
Sci Rep. 2016 Jun 10;6:26351
pubmed: 27283076
Sci Rep. 2017 Apr 05;7:45983
pubmed: 28378811
PLoS One. 2015 May 08;10(5):e0123830
pubmed: 25955657
Sci Rep. 2016 Feb 15;6:21524
pubmed: 26876154
PLoS One. 2013 Sep 13;8(9):e74611
pubmed: 24058603
Oncol Lett. 2016 Mar;11(3):1980-1986
pubmed: 26998110
N Engl J Med. 2015 Nov 12;373(20):1979
pubmed: 26559582
Medicine (Baltimore). 2017 Oct;96(42):e8241
pubmed: 29049212
Clin Cancer Res. 2009 Jun 1;15(11):3827-33
pubmed: 19435835
Oncotarget. 2017 Jul 4;8(27):44171-44185
pubmed: 28498807
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Cancer Res. 2007 Feb 15;67(4):1602-8
pubmed: 17308100
Science. 2007 Nov 16;318(5853):1108-13
pubmed: 17932254
EMBO Rep. 2016 Dec;17(12):1721-1730
pubmed: 27856534
Expert Opin Ther Pat. 2018 Jan;28(1):61-68
pubmed: 28994333